Site icon OncologyTube

Use of HER2, BRAF, and Immunotherapy in Clinical Practice

Tanios S. Bekaii-Saab, MD, FACP of Mayo Clinic explains how to integrate HER2, BRAF, and immunotherapy into clinical practice. This was recorded at the 2017 Great Debates and Updates in GI Malignancies in New York, NY.

Exit mobile version